Cargando…
After having changed the treatment of heart failure with reduced ejection fraction: what are the latest evidences with sacubitril valsartan?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Science Press
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431599/ https://www.ncbi.nlm.nih.gov/pubmed/30923547 http://dx.doi.org/10.11909/j.issn.1671-5411.2019.02.009 |
| _version_ | 1783405952213450752 |
|---|---|
| author | Kaplinsky, Edgardo |
| author_facet | Kaplinsky, Edgardo |
| author_sort | Kaplinsky, Edgardo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6431599 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Science Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64315992019-03-28 After having changed the treatment of heart failure with reduced ejection fraction: what are the latest evidences with sacubitril valsartan? Kaplinsky, Edgardo J Geriatr Cardiol Editorial Science Press 2019-02 /pmc/articles/PMC6431599/ /pubmed/30923547 http://dx.doi.org/10.11909/j.issn.1671-5411.2019.02.009 Text en Institute of Geriatric Cardiology http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License, which allows readers to alter, transform, or build upon the article and then distribute the resulting work under the same or similar license to this one. The work must be attributed back to the original author and commercial use is not permitted without specific permission. |
| spellingShingle | Editorial Kaplinsky, Edgardo After having changed the treatment of heart failure with reduced ejection fraction: what are the latest evidences with sacubitril valsartan? |
| title | After having changed the treatment of heart failure with reduced ejection fraction: what are the latest evidences with sacubitril valsartan? |
| title_full | After having changed the treatment of heart failure with reduced ejection fraction: what are the latest evidences with sacubitril valsartan? |
| title_fullStr | After having changed the treatment of heart failure with reduced ejection fraction: what are the latest evidences with sacubitril valsartan? |
| title_full_unstemmed | After having changed the treatment of heart failure with reduced ejection fraction: what are the latest evidences with sacubitril valsartan? |
| title_short | After having changed the treatment of heart failure with reduced ejection fraction: what are the latest evidences with sacubitril valsartan? |
| title_sort | after having changed the treatment of heart failure with reduced ejection fraction: what are the latest evidences with sacubitril valsartan? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6431599/ https://www.ncbi.nlm.nih.gov/pubmed/30923547 http://dx.doi.org/10.11909/j.issn.1671-5411.2019.02.009 |
| work_keys_str_mv | AT kaplinskyedgardo afterhavingchangedthetreatmentofheartfailurewithreducedejectionfractionwhatarethelatestevidenceswithsacubitrilvalsartan |